|
|
|
| Comparative Study of Efficacy of Trepanation and Drainage and Bone Flap Craniotomy Hematoma Evacuation combined with Decompressive Craniectomy in the Treatment of Aspirin-related Supratentorial Cerebral Hemorrhage |
| SHEN Yu, XU Chunlin, CHENG Xiaozhi, et al |
| Huanggang Central Hospital, Hubei Huanggang 438000, China |
|
|
|
|
Abstract Objective: To study the efficacy and safety of trepanation and drainage and bone flap craniotomy hematoma evacuation combined with decompressive craniectomy in the treatment of aspirin (ASA)-related supratentorial cerebral hemorrhage (SCH). Methods: 84 patients with ASA-related SCH in our hospital from September 2015 to September 2018 were selected and divided into trepanation group and craniotomy group according to the simple randomization method, with 42 cases in each group. Trepanation group was given trepanation and drainage, and craniotomy group was given small bone window craniotomy hematoma evacuation and decompressive craniectomy. The hematoma clearance rate, the NIHSS score, GCS score and GOS score at 24 h after operation, ability of daily living at 6 months after operation, incidence rate of postoperative complications and mortality rate of patients were compared between the two groups. Results: The operative time, intraoperative blood loss, drainage time and hospital stay in trepanation group were significantly lower than those in craniotomy group (P<0.05), and there was no significant difference in the hematoma clearance rate between the two groups (P>0.05). At 24h after operation, the NIHSS score in the two groups was significantly decreased (P<0.05) while the scores of GCS and GOS were significantly increased (P<0.05), and the NIHSS score in trepanation group was lower than that in craniotomy group while the scores of GCS and GOS were higher than those in control group (P<0.05). At 6 months after operation, the ability of daily living in trepanation group was significantly better than that in craniotomy group (P<0.05), and the excellent and good rate of ability of daily living in the two groups were 90.24% and 84.21% respectively (P>0.05). The incidence rates of complications in trepanation group and craniotomy group were 21.43% and 19.05% respectively (P>0.05), and the mortality rates were 2.38% and 4.76% respectively (P>0.05). Conclusions: Compared with craniotomy hematoma evacuation combined with decompressive craniectomy, trepanation and puncture drainage has simpler operation, smaller trauma and quicker postoperative recovery, and it can effectively reduce NIHSS score, enhance scores of GCS and GOS and improve postoperative daily living ability, and increase significantly the incidence rate of postoperative complications.
|
|
|
|
|
|
[1] Albertson M,Sharma J.Stroke:current concepts[J].S D Med,2014,67(11):455,457~461,463~465.
[2] Liu H,Zen Y,Li J,et al.Optimal treatment determination on the basis of haematoma volume and intra-cerebral haemorrhage score in patients with hypertensive putaminal haemorrhages:a retrospective analysis of 310 patients[J].BMC Neurol,2014,14(1):141~146.
[3] Cea Soriano L,Lucía,Gaist D,Soriano-GabarróM,et al.Incidence of intracranial bleeds in new users of low-dose aspirin:a cohort study using The Health Improvement Network[J].Thromb Haemost,2017,15(6):1055~1064.
[4] Gang Y,Gaofeng S.Clinical effect of minimally invasive intracranial hematoma in treating hypertensive cerebral hemorrhage[J].Pak Med Sci,2016,32(3):677~681.
[5] 曲良锁,毛涌馨,张文怡,等.长期服用阿司匹林的脑出血患者急症手术治疗[J].中华神经外科疾病研究杂志,2015,14(1):33~36.
[6] 蔡景芬,吴茂铸,蔡卫东,等.Orem自理模式对多发性硬化患者日常生活能力和不良情绪的影响[J].中华全科医学,2014,12(2):300~302.
[7] Kernan WN,Ovbiagele B,Black HR,et a1.Guidelines for the prevention of stroke in patients with stroke and Transient Ischemic Attack:A guideline for heahhcare professionals from the American Heart Association/American Stroke Association[J].Stroke,2014,45(7):2160~2236.
[8] 史立信,臧颖卓,王清涛,等.阿司匹林相关性脑出血患者的预后、部分凝血指标改变与对策[J].脑与神经疾病杂志,2016,24(04):236~240.
[9] Kawai VK,Avalos I,Oeser A,et al.Suboptimal inhibition of platelet cyclo-oxygenase-1(COX-1)by aspirin in lupus erythematosus:Association with metabolic syndrome[J].Arthritis Care&Research,2014,66(2):285~292. |
|
|
|
2019, Vol. 25 
